Researchers at the Research Center Borstel, Leibniz Lung Center (FZB) and the German Center for Infection Research (DZIF) have identified a novel whole blood-based immune signature that could improve
Researchers from the University of Cologne, the German Center for Infection Research (DZIF), and the Broad Institute of Harvard and MIT present a remarkable clinical case in the New England Journal of
More than a quarter of the world's population is affected by helminth infections, which can profoundly alter the immune system. In a preclinical study, researchers found that mRNA- and protein-based
Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known as phages. A research project funded by the European
Researchers in Eswatini, in collaboration with an international consortium, have made a significant breakthrough in tuberculosis (TB) diagnostics. Using targeted genome sequencing, they detected drug
Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for
On June 12, 2026, the Parliamentary Group against Antimicrobial Resistance (PKAMR) held a discussion under the title "High-tech agenda for antibiotics—strategic directions for innovation and security
Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. The danger is
Qubigen, a company specializing in AI-driven drug discovery, recently announced the launch of a new collaborative project focused on the decentralized (federated) AI-driven design of antiviral
